Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Nasdaq Pharmaceuticals ETF (FTXH)

Nasdaq Pharmaceuticals ETF (FTXH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family First Trust Portfolios
  • Assets Under Management 16,428,000
  • Shares Outstanding, K 600
  • 60-Month Beta 0.70
  • Price/Earnings ttm 16.59
  • Annual Dividend & Yield 0.44 (1.61%)
  • Most Recent Dividend 0.122 on 09/26/24
  • Management Fee 0.60%
  • Sectors:

    ETFs - Large Cap

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.83 +2.05%
on 11/19/24
29.31 -6.60%
on 11/11/24
-1.43 (-4.96%)
since 10/18/24
3-Month
26.83 +2.05%
on 11/19/24
29.72 -7.87%
on 08/29/24
-1.78 (-6.12%)
since 08/20/24
52-Week
24.37 +12.36%
on 11/28/23
29.72 -7.87%
on 08/29/24
+2.79 (+11.36%)
since 11/20/23

Most Recent Stories

More News
ETFs in Focus Post JNJ Q3 Earnings Beat, Target Price Hike

Johnson & Johnson JNJ infused positive optimism for the broader healthcare sector after posting solid third-quarter 2024 earnings on Oct. 15. The world's biggest healthcare products maker continued with...

XLV : 142.88 (+1.18%)
JNJ : 153.11 (+0.07%)
IHE : 67.40 (+1.06%)
IYH : 60.17 (+1.14%)
PPH : 87.44 (+0.66%)
FTXH : 27.38 (+0.92%)
Do Wall Street Analysts Like Gilead Sciences Stock?

Gilead Sciences has underperformed the broader market over the past year, yet Wall Street analysts remain moderately bullish about the stock’s prospects.

GILD : 88.63 (+1.00%)
$SPX : 5,917.11 (unch)
FTXH : 27.38 (+0.92%)
Bristol-Myers Squibb Stock: Analyst Estimates & Ratings

Bristol-Myers Squibb has underperformed the market over the past year, and Wall Street analysts remain cautious about the stock prospects.

BMY : 57.88 (-0.60%)
$SPX : 5,917.11 (unch)
FTXH : 27.38 (+0.92%)
MS : 131.69 (-0.42%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 138 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.

FCAL : 49.93 (+0.26%)
FEMB : 27.07 (-0.11%)
FMB : 51.47 (-0.12%)
FMHI : 48.88 (-0.06%)
RFDI : 62.87 (-0.22%)
RFEM : 63.96 (-0.34%)
RFEU : 61.64 (+0.29%)
FTSL : 46.47 (+0.09%)
FTSM : 59.90 (-0.03%)
HISF : 44.25 (+0.01%)
HYLS : 41.76 (-0.02%)
LMBS : 48.77 (+0.02%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 129 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.

FCAL : 49.93 (+0.26%)
FEMB : 27.07 (-0.11%)
FMB : 51.47 (-0.12%)
FMHI : 48.88 (-0.06%)
RFDI : 62.87 (-0.22%)
RFEM : 63.96 (-0.34%)
RFEU : 61.64 (+0.29%)
FCVT : 37.74 (+0.77%)
FTSL : 46.47 (+0.09%)
HISF : 44.25 (+0.01%)
HYLS : 41.76 (-0.02%)
LMBS : 48.77 (+0.02%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 135 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.

FCAL : 49.93 (+0.26%)
FEMB : 27.07 (-0.11%)
FMB : 51.47 (-0.12%)
FMHI : 48.88 (-0.06%)
RFDI : 62.87 (-0.22%)
RFEM : 63.96 (-0.34%)
RFEU : 61.64 (+0.29%)
FCVT : 37.74 (+0.77%)
FTSL : 46.47 (+0.09%)
HISF : 44.25 (+0.01%)
HYLS : 41.76 (-0.02%)
LMBS : 48.77 (+0.02%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 120 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.

FCAL : 49.93 (+0.26%)
FEMB : 27.07 (-0.11%)
FMB : 51.47 (-0.12%)
FMHI : 48.88 (-0.06%)
RFDI : 62.87 (-0.22%)
RFEU : 61.64 (+0.29%)
FCVT : 37.74 (+0.77%)
FTSL : 46.47 (+0.09%)
HISF : 44.25 (+0.01%)
HYLS : 41.76 (-0.02%)
LMBS : 48.77 (+0.02%)
FTHI : 23.63 (-0.08%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 133 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.

FCAL : 49.93 (+0.26%)
FEMB : 27.07 (-0.11%)
FMB : 51.47 (-0.12%)
FMHI : 48.88 (-0.06%)
RFDI : 62.87 (-0.22%)
RFEM : 63.96 (-0.34%)
RFEU : 61.64 (+0.29%)
FCVT : 37.74 (+0.77%)
FDIV : 27.99 (-0.25%)
FTSL : 46.47 (+0.09%)
FTSM : 59.90 (-0.03%)
HYLS : 41.76 (-0.02%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 122 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.

FCAL : 49.93 (+0.26%)
FEMB : 27.07 (-0.11%)
FMB : 51.47 (-0.12%)
FMHI : 48.88 (-0.06%)
RFDI : 62.87 (-0.22%)
RFEM : 63.96 (-0.34%)
RFEU : 61.64 (+0.29%)
FCVT : 37.74 (+0.77%)
FDIV : 27.99 (-0.25%)
FTSL : 46.47 (+0.09%)
HYLS : 41.76 (-0.02%)
LMBS : 48.77 (+0.02%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 122 exchange-traded funds (each a “Fund,” collectively, the “Funds”) advised by FTA.

FCAL : 49.93 (+0.26%)
FEMB : 27.07 (-0.11%)
FMB : 51.47 (-0.12%)
FMHI : 48.88 (-0.06%)
RFAP : 58.36 (+1.32%)
RFDI : 62.87 (-0.22%)
RFEM : 63.96 (-0.34%)
RFEU : 61.64 (+0.29%)
FCVT : 37.74 (+0.77%)
FDIV : 27.99 (-0.25%)
FTSL : 46.47 (+0.09%)
HYLS : 41.76 (-0.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Fund Summary

The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks...

See More

Key Turning Points

3rd Resistance Point 27.44
2nd Resistance Point 27.41
1st Resistance Point 27.40
Last Price 27.38
1st Support Level 27.35
2nd Support Level 27.32
3rd Support Level 27.30

See More

52-Week High 29.72
Fibonacci 61.8% 27.68
Last Price 27.38
Fibonacci 50% 27.04
Fibonacci 38.2% 26.41
52-Week Low 24.37

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar